Oppenheimer & Co’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$598K Buy
18,993
+695
+4% +$21.9K 0.01% 1112
2025
Q4
$539K Buy
18,298
+650
+4% +$18.1K 0.01% 1048
2025
Q3
$446K Sell
17,648
-1,406
-7% -$34.3K 0.01% 1226
2025
Q2
$457K Sell
19,054
-900
-5% -$20.9K 0.01% 1173
2025
Q1
$457K Sell
19,954
-458
-2% -$11.1K 0.01% 1103
2024
Q4
$517K Sell
20,412
-35,192
-63% -$892K 0.01% 1048
2024
Q3
$1.39M Buy
55,604
+34,687
+166% +$1.03M 0.02% 679
2024
Q2
$620K Sell
20,917
-15,505
-43% -$430K 0.01% 931
2024
Q1
$1.1M Buy
36,422
+14,667
+67% +$407K 0.02% 708
2023
Q4
$622K Buy
21,755
+1,858
+9% +$54.6K 0.01% 899
2023
Q3
$737K Buy
+19,897
New +$760K 0.02% 785

Other funds holding RTO

Oppenheimer & Co's RTO Position: Q1 2026 in Review

Oppenheimer & Co increased its Rentokil (RTO) stake by 3.8% in Q1 2026, buying an estimated $21.9K and bringing the position to 18,993 shares worth $598K. The position accounts for 0.01% of the portfolio, ranked #1112.

Oppenheimer & Co first reported a position in RTO in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.39M in Q3 2024. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Oppenheimer & Co held 18,993 shares of Rentokil worth $598K as of Q1 2026.
  • Oppenheimer & Co bought 695 Rentokil shares in Q1 2026, an estimated $21.9K.
  • Rentokil made up 0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1112 holding.
  • Oppenheimer & Co first reported a position in Rentokil in Q3 2023 and has held it in 11 quarters since.
  • Oppenheimer & Co's Rentokil position peaked at $1.39M in Q3 2024.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.